Palatin Technologies, Inc. (PTN)
5.52
-0.47
(-7.85%)
USD |
NASDAQ |
Oct 20, 16:00
5.60
+0.08
(+1.45%)
After-Hours: 20:00
Palatin Technologies Max Drawdown (5Y) : 99.74% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 99.74% |
| August 31, 2026 | 99.74% |
| July 31, 2026 | 99.74% |
| June 30, 2026 | 99.74% |
| May 31, 2026 | 99.74% |
| April 30, 2026 | 99.74% |
| March 31, 2026 | 99.74% |
| February 28, 2026 | 99.74% |
| January 31, 2026 | 99.74% |
| December 31, 2025 | 99.74% |
| November 30, 2025 | 99.74% |
| October 31, 2025 | 99.74% |
| September 30, 2025 | 99.74% |
| August 31, 2025 | 99.74% |
| July 31, 2025 | 99.74% |
| June 30, 2025 | 99.74% |
| May 31, 2025 | 99.74% |
| April 30, 2025 | 99.47% |
| March 31, 2025 | 98.13% |
| February 28, 2025 | 97.60% |
| January 31, 2025 | 97.60% |
| December 31, 2024 | 97.60% |
| November 30, 2024 | 97.38% |
| October 31, 2024 | 97.38% |
| September 30, 2024 | 97.31% |
| Date | Value |
|---|---|
| August 31, 2024 | 96.46% |
| July 31, 2024 | 96.46% |
| June 30, 2024 | 96.46% |
| May 31, 2024 | 96.46% |
| April 30, 2024 | 96.46% |
| March 31, 2024 | 96.46% |
| February 29, 2024 | 96.46% |
| January 31, 2024 | 96.46% |
| December 31, 2023 | 96.46% |
| November 30, 2023 | 96.46% |
| October 31, 2023 | 96.46% |
| September 30, 2023 | 96.46% |
| August 31, 2023 | 95.51% |
| July 31, 2023 | 95.51% |
| June 30, 2023 | 94.95% |
| May 31, 2023 | 94.88% |
| April 30, 2023 | 94.59% |
| March 31, 2023 | 94.59% |
| February 28, 2023 | 94.59% |
| January 31, 2023 | 94.59% |
| December 31, 2022 | 94.59% |
| November 30, 2022 | 90.61% |
| October 31, 2022 | 89.51% |
| September 30, 2022 | 89.51% |
| August 31, 2022 | 88.80% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 77.18% |
| Alnylam Pharmaceuticals, Inc. | 58.17% |
| Anika Therapeutics, Inc. | 83.15% |
| Savara, Inc. | 93.79% |
| Vericel Corp. | 73.97% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -66.34 |
| Beta (5Y) | 0.6302 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 127.8% |
| Historical Sharpe Ratio (5Y) | -0.4699 |
| Historical Sortino (5Y) | -1.117 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 43.95% |